Corcept faces securities fraud lawsuit over FDA drug rejection

March 13, 2026 9:51 PM

Law firm Kahn Swick & Foti filed a securities class action lawsuit against Corcept Therapeutics Incorporated (NASDAQ: CORT) in the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found